← Back to home

ADULTS WITH HEART FAILURE, MILD DECREASE IN EJECTION FRACTION/PRESERVED EJECTION FRACTION, AND OBESITY

Clinical trials for ADULTS WITH HEART FAILURE, MILD DECREASE IN EJECTION FRACTION/PRESERVED EJECTION FRACTION, AND OBESITY explained in plain language.

Never miss a new study

Get alerted when new ADULTS WITH HEART FAILURE, MILD DECREASE IN EJECTION FRACTION/PRESERVED EJECTION FRACTION, AND OBESITY trials appear

Sign up with your email to follow new studies for ADULTS WITH HEART FAILURE, MILD DECREASE IN EJECTION FRACTION/PRESERVED EJECTION FRACTION, AND OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial targets weight and heart health together

Disease control Recruiting now

This study is testing whether an investigational drug called HRS-7535 can help adults who have both heart failure and obesity. About 225 participants will receive either the drug or a placebo for 36 weeks to see if it helps with weight control and heart failure symptoms. The main…

Matched conditions: ADULTS WITH HEART FAILURE, MILD DECREASE IN EJECTION FRACTION/PRESERVED EJECTION FRACTION, AND OBESITY

Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control

Last updated Apr 01, 2026 14:48 UTC

ADULTS WITH HEART FAILURE, MILD DECREASE IN EJECTION FRACTION/PRESERVED EJECTION FRACTION, AND OBESITY

Get alerted when new ADULTS WITH HEART FAILURE, MILD DECREASE IN EJECTION FRACTION/PRESERVED EJECTION FRACTION, AND OBESITY trials appear

New drug trial targets weight and heart health together